Table 1 Baseline characteristics of study population (n = 148)

Demographic finding

  Age (yr)

67.1 ± 9.0

  Male sex

108 (73.0)

  Body mass index (kg/m²)

25.9 ± 3.5

Comorbidity

  Coronary artery disease

98 (66.2)

  Ischemic stroke

15 (10.1)

  Hypertension

110 (74.3)

  Diabetes mellitus

62 (41.9)

  Current smoking

38 (25.1)

Laboratory finding

  White blood cell count (/µL)

7,290 ± 5,240

  Hemoglobin (g/dL)

14.0 ± 1.5

  Cholesterol (mg/dL)

150 ± 30

  Low-density lipoprotein cholesterol (mg/dL)

78.3 ± 24.1

  High-density lipoprotein cholesterol (mg/dL)

47.6 ± 11.7

  Triglyceride (mg/dL)

135 ± 83

  Fasting blood glucose (mg/dL)

119 ± 33

  Glycated hemoglobin (%)

6.35 ± 1.09

  C-reactive protein (mg/dL)

0.96 ± 6.89

  NT-proBNP (pg/mL)

326 ± 515

Medication

  Antiplatelet agent

131 (88.5)

  Calcium channel blocker

73 (48.7)

  Renin-angiotensin system blocker

121 (81.8)

  Beta-blocker

107 (71.3)

  Statin

136 (90.7)